Noninvasive cancer detection by extracting and integrating multi-modal data from whole-methylome sequencing of plasma cell-free DNA

Fenglong Bie(Chinese Academy of Medical Sciences & Peking Union Medical College), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Bolun Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Peng Song(Chinese Academy of Medical Sciences & Peking Union Medical College), Weizhi Chen(Genecast (China)), Ruochuan Zang(Chinese Academy of Medical Sciences & Peking Union Medical College), Shunli Yang(Genecast (China)), Qilin Huai(Chinese Academy of Medical Sciences & Peking Union Medical College), Fengwei Tan(Chinese Academy of Medical Sciences & Peking Union Medical College), Suxing Li(Genecast (China)), Tiancheng Han(Genecast (China)), Peiyao Nie(Genecast (China)), Yuanyuan Hong(Genecast (China)), Jianchun Duan(Chinese Academy of Medical Sciences & Peking Union Medical College), Fang Lv(Genecast (China)), Yulong Li(Shanxi Medical University), Xi Li(Genecast (China)), Zhijie Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Feiyue Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), Guangyu Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Guo(Chinese Academy of Agricultural Sciences), Moyan Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Yu Huang(Genecast (China))
bioRxiv (Cold Spring Harbor Laboratory)
July 5, 2022
10.1101/2022.07.04.498641
Cited by 3

Related Papers

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2024|233
Microrobotic swarms for selective embolization
|Science Advances|2022|128
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
|Cell|2025|103
Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy
|Cancer Science|2023|90
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma
|Frontiers in Immunology|2021|84